conferito da Conference on Retroviruses and Opportunistic Infections
- 2015
- Poster: RANKL predicts 96-week BMD changes in ATV/r monotherapy: a MODAt trial sub-study
conferito da Conference on Retroviruses and Opportunistic Infections
- 2013
- Poster 766: Association between HMG-CoA reductase inhibitors (statins) use and type-2 diabetes mellitus occurrence among HIV-1 treated patients